Renaissance Technologies - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 72 filers reported holding LEAP THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$155
-62.8%
455,200
-50.8%
0.00%
-100.0%
Q4 2022$417
-99.9%
925,700
+136.6%
0.00%
Q3 2022$344,000
-51.8%
391,300
-37.0%
0.00%
-100.0%
Q2 2022$714,000
+269.9%
620,820
+943.4%
0.00%
Q4 2021$193,000
-95.1%
59,500
-93.9%
0.00%
-100.0%
Q3 2021$3,903,000
+1214.1%
973,200
+436.8%
0.01%
Q2 2021$297,000
+412.1%
181,285
+492.4%
0.00%
Q1 2021$58,000
-92.2%
30,600
-90.7%
0.00%
-100.0%
Q4 2020$744,000
-46.2%
330,500
-52.7%
0.00%0.0%
Q3 2020$1,383,000
+38.6%
698,700
+46.3%
0.00%0.0%
Q2 2020$998,000
+265.6%
477,498
+176.3%
0.00%
Q1 2020$273,000
-16.3%
172,801
+6.1%
0.00%
Q4 2018$326,000
-69.9%
162,914
+17.3%
0.00%
-100.0%
Q3 2018$1,082,000
-38.6%
138,868
-31.5%
0.00%0.0%
Q2 2018$1,761,000
+135.1%
202,687
+124.7%
0.00%0.0%
Q1 2018$749,000
+307.1%
90,220
+222.8%
0.00%
Q2 2017$184,000
-55.9%
27,945
-38.5%
0.00%
-100.0%
Q1 2017$417,00045,4450.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders